Dare Bioscience, Inc. (DARE) earnings
DARE earnings moved a median of 0.00% by the close. Quarterly and annual DARE reports and results, each read against the price at its own news timestamp. Back to the DARE overview →
28 measured DARE earnings events.
Where these DARE earnings landedvs 28 measured DARE earnings reactions
| Middle 50% of DARE earnings reactions | -5.39% to +0.78% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 28 |
Point-in-time · zero look-ahead
Half of the 28 DARE earnings events with a measured close landed between -5.39% and +0.78%; 43% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Daré Bioscience Reports Second Quarter 2026 Results and Highlights Commercial Inflection as Multi-Product Women’s Health Strategy Advances | Press release | -4.39% | -40.00% | |
| Form 10-Q Dare Bioscience, Inc. For: Jun 30 | SEC filing · Form 10-Q | -4.39% | -40.00% | |
| Daré Bioscience to Host Second Quarter 2026 Financial Results and Company Update Conference Call and Webcast on August 13, 2026 | Press release | -1.88% | +0.00% | |
| Daré Bioscience Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | +0.00% | -1.36% | |
| Form 10-Q Dare Bioscience, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -1.36% | |
| Daré Bioscience to Host First Quarter 2026 Financial Results and Company Update Conference Call and Webcast on May 14, 2026 | Press release | -3.93% | -4.59% | |
| Form 10-K Dare Bioscience, Inc. For: Dec 31 | SEC filing · Form 10-K | -3.02% | +0.00% | |
| Daré Bioscience to Host Third Quarter 2025 Financial Results and Company Update Conference Call and Webcast on November 13, 2025 | Press release | +0.00% | -2.69% | |
| Daré Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate Update | Press release | +5.48% | +0.46% | |
| Form 10-Q Dare Bioscience, Inc. For: Jun 30 | SEC filing · Form 10-Q | +5.48% | +0.46% | |
| Daré Bioscience to Host Second Quarter 2025 Financial Results and Company Update Conference Call and Webcast on August 14, 2025 | Press release | +0.66% | -9.73% | |
| Daré Bioscience Reports First Quarter 2025 Financial Results and Provides Company Update | Press release | +0.00% | +0.35% | |
| Form 10-Q Dare Bioscience, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +0.35% | |
| Daré Bioscience to Host First Quarter 2025 Financial Results and Company Update Conference Call and Webcast on May 13, 2025 | Press release | +0.00% | -2.69% | |
| Form 10-K Dare Bioscience, Inc. For: Dec 31 | SEC filing · Form 10-K | -1.04% | +0.69% | |
| Daré Bioscience Reports Third Quarter 2024 Financial Results and Provides Company Update | Press release | +0.00% | -8.55% | |
| Form 10-Q Dare Bioscience, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -8.55% | |
| Daré Bioscience to Host Third Quarter 2024 Financial Results and Company Update Conference Call and Webcast on November 14, 2024 | Press release | +0.00% | +2.02% | |
| Daré Bioscience Reports Second Quarter 2024 Financial Results and Provides Company Update | Press release | -2.12% | +11.41% | |
| Form 10-Q Dare Bioscience, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.12% | +11.41% | |
| Daré Bioscience to Host Second Quarter 2024 Financial Results and Company Update Conference Call and Webcast on August 12, 2024 | Press release | +0.00% | -0.52% | |
| Daré Bioscience Reports First Quarter 2024 Financial Results and Provides Company Update | Press release | +1.64% | +1.61% | |
| Form 10-Q Dare Bioscience, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +9.09% | |
| Daré Bioscience to Host First Quarter 2024 Financial Results and Company Update Conference Call and Webcast on May 14, 2024 | Press release | +0.00% | +3.33% | |
| Form 10-K Dare Bioscience, Inc. For: Dec 31 | SEC filing · Form 10-K | +2.04% | +1.04% | |
| Daré Bioscience Reports Third Quarter 2023 Financial Results and Provides Company Update | Press release | +4.96% | -7.79% | |
| Form 10-Q Dare Bioscience, Inc. For: Sep 30 | SEC filing · Form 10-Q | +8.52% | +0.00% | |
| Daré Bioscience to Host Third Quarter 2023 Financial Results and Company Update Conference Call and Webcast on November 9, 2023 | Press release | -0.57% | -10.68% |
Keep exploring
More DARE: analyst actions → · SEC filings → · DARE overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| IKANG HEALTH CARE GROUP (KANG) | 242 | -0.07% | 44% |
| Adial Pharmaceuticals, Inc (ADIL) | 241 | 0.00% | 44% |
| Genprex, Inc. (GNPX) | 241 | -1.17% | 33% |
| Allakos Inc. (ALLK) | 240 | -0.70% | 35% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.